The NIMH matrics initiative: Development of a Consensus Cognitive Battery

Robert S. Kern; Michael F. Green; Stephen R. Marder

doi:10.1017/s1748232106000127

The NIMH matrics initiative: Development of a Consensus Cognitive Battery

Robert S. Kern, Michael F. Green, Stephen R. Marder

University of California at Los Angeles

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

A key obstacle to the development of new drugs to treat the cognitive deficits of schizophrenia was the absence of a standard by which to measure their efficacy. Before granting approval for any new drug for this condition, the US Food and Drug Administration wanted a standard cognitive endpoint based on a broad consensus-based method. To address this obstacle, the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) intiative oversaw a process to develop a consensus neurocognitive battery. Its development included a ten-step process that is described in this article.

Original language	English
Pages (from-to)	173-186
Number of pages	14
Journal	Progress in Neurotherapeutics and Neuropsychopharmacology
Volume	2
Issue number	1
DOIs	https://doi.org/10.1017/s1748232106000127
State	Published - Mar 2007
Externally published	Yes

Keywords

cognition
schizophrenia
tests and measurement

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1017/s1748232106000127

Cite this

@article{66b75a05c6c04f4f983050b8031d6532,

title = "The NIMH matrics initiative: Development of a Consensus Cognitive Battery",

abstract = "A key obstacle to the development of new drugs to treat the cognitive deficits of schizophrenia was the absence of a standard by which to measure their efficacy. Before granting approval for any new drug for this condition, the US Food and Drug Administration wanted a standard cognitive endpoint based on a broad consensus-based method. To address this obstacle, the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) intiative oversaw a process to develop a consensus neurocognitive battery. Its development included a ten-step process that is described in this article.",

keywords = "cognition, schizophrenia, tests and measurement",

author = "Kern, {Robert S.} and Green, {Michael F.} and Marder, {Stephen R.}",

year = "2007",

month = mar,

doi = "10.1017/s1748232106000127",

language = "אנגלית",

volume = "2",

pages = "173--186",

journal = "Progress in Neurotherapeutics and Neuropsychopharmacology",

issn = "1748-2321",

publisher = "Cambridge University Press",

number = "1",

}

TY - JOUR

T1 - The NIMH matrics initiative

T2 - Development of a Consensus Cognitive Battery

AU - Kern, Robert S.

AU - Green, Michael F.

AU - Marder, Stephen R.

PY - 2007/3

Y1 - 2007/3

N2 - A key obstacle to the development of new drugs to treat the cognitive deficits of schizophrenia was the absence of a standard by which to measure their efficacy. Before granting approval for any new drug for this condition, the US Food and Drug Administration wanted a standard cognitive endpoint based on a broad consensus-based method. To address this obstacle, the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) intiative oversaw a process to develop a consensus neurocognitive battery. Its development included a ten-step process that is described in this article.

AB - A key obstacle to the development of new drugs to treat the cognitive deficits of schizophrenia was the absence of a standard by which to measure their efficacy. Before granting approval for any new drug for this condition, the US Food and Drug Administration wanted a standard cognitive endpoint based on a broad consensus-based method. To address this obstacle, the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) intiative oversaw a process to develop a consensus neurocognitive battery. Its development included a ten-step process that is described in this article.

KW - cognition

KW - schizophrenia

KW - tests and measurement

UR - http://www.scopus.com/inward/record.url?scp=85011436420&partnerID=8YFLogxK

U2 - 10.1017/s1748232106000127

DO - 10.1017/s1748232106000127

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

AN - SCOPUS:85011436420

SN - 1748-2321

VL - 2

SP - 173

EP - 186

JO - Progress in Neurotherapeutics and Neuropsychopharmacology

JF - Progress in Neurotherapeutics and Neuropsychopharmacology

IS - 1

ER -

The NIMH matrics initiative: Development of a Consensus Cognitive Battery

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this